Covid-19 vaccines and treatments: we must have raw data, now The authors of this paper, published in

Jan 28, 2022
Upload Media

Covid-19 vaccines and treatments: we must have raw data, now

The authors of this paper, published in BMJ, say people don't have access to real, good (raw) data on the vaccines.

In the paper, they write, "The anonymized participant level of data underlying the trials for these new products remain inaccessible to doctors, researchers, and the public" despite the global rollout.

The authors asserted that, "This is morally indefensible for all trials, but especially for those involving major public health interventions."

"The company and the contract research organization that carried out the trial hold all the data."

Pfizer indicated it wouldn't even begin to entertain requests for trial data until 2025.

It has been pointed out that a similar thing happened in 2009 - 2012 there was a large vaccination campaign for H1N1, and governments were stockpiling Tamiflu,how much did tamiflu make (UK spent 473m pounds on it. Anyone know how much it's made worldwide?) and there was a black market for the product. Major trials for it were sponsored by the manufacturer, and papers were ghostwritten and paid for by the manufacturers. Academics who requested access to the papers were denied.

Tamiflu: the battle for secret drug data

#MIC #Pharma
Update Post

<b><a target="_blank" href="https://www.bmj.com/content/376/bmj.o102">Covid-19 vaccines and treatments: we must have raw data, now</a></b> <br><div><br></div><div>The authors of this paper, published in BMJ, say people don't have access to real, good (raw) data on the vaccines. <br></div><div><br></div><div>In the paper, they write, "The anonymized participant level of data underlying the trials for these new products remain inaccessible to doctors, researchers, and the public" despite the global rollout. <br></div><div><br></div><div>The authors asserted that, "This is morally indefensible for all trials, but especially for those involving major public health interventions."</div><div><br></div><div>"The company and the contract research organization that carried out the trial hold all the data."<br><br>Pfizer indicated it wouldn't even begin to entertain requests for trial data until 2025.<br></div><div><br></div><div>It has been pointed out that a similar thing happened in 2009 - 2012 there was a large vaccination campaign for H1N1, and governments were stockpiling Tamiflu,how much did tamiflu make (UK spent 473m pounds on it. Anyone know how much it's made worldwide?) and there was a black market for the product. Major trials for it were sponsored by the manufacturer, and papers were ghostwritten and paid for by the manufacturers. Academics who requested access to the papers were denied. <br></div><div><br></div><div><a target="_blank" href="https://www.bmj.com/content/345/bmj.e7303">Tamiflu: the battle for secret drug data</a></div><div><br></div><div><a href="http://landandseajournal.com/post/hashtag/MIC"><a href="http://landandseajournal.com/post/hashtag/MIC">#MIC</a></a> <a href="http://landandseajournal.com/post/hashtag/Pharma"><a href="http://landandseajournal.com/post/hashtag/Pharma">#Pharma</a></a></div>
Covid-19 vaccines and treatments: we must have raw data, now

The authors of this paper, published in BMJ, say people don't have access to real, good (raw) data on the vaccines.

In the paper, they write, "The anonymized participant level of data underlying the trials for these new products remain inaccessible to doctors, researchers, and the public" despite the global rollout.

The authors asserted that, "This is morally indefensible for all trials, but especially for those involving major public health interventions."

"The company and the contract research organization that carried out the trial hold all the data."

Pfizer indicated it wouldn't even begin to entertain requests for trial data until 2025.

It has been pointed out that a similar thing happened in 2009 - 2012 there was a large vaccination campaign for H1N1, and governments were stockpiling Tamiflu,how much did tamiflu make (UK spent 473m pounds on it. Anyone know how much it's made worldwide?) and there was a black market for the product. Major trials for it were sponsored by the manufacturer, and papers were ghostwritten and paid for by the manufacturers. Academics who requested access to the papers were denied.

Tamiflu: the battle for secret drug data

#MIC #Pharma

Show More

Show Less

Comments